Ingo Klare

6.6k total citations
98 papers, 4.4k citations indexed

About

Ingo Klare is a scholar working on Infectious Diseases, Clinical Biochemistry and Molecular Biology. According to data from OpenAlex, Ingo Klare has authored 98 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Infectious Diseases, 44 papers in Clinical Biochemistry and 22 papers in Molecular Biology. Recurrent topics in Ingo Klare's work include Antimicrobial Resistance in Staphylococcus (73 papers), Bacterial Identification and Susceptibility Testing (44 papers) and Antibiotic Resistance in Bacteria (21 papers). Ingo Klare is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (73 papers), Bacterial Identification and Susceptibility Testing (44 papers) and Antibiotic Resistance in Bacteria (21 papers). Ingo Klare collaborates with scholars based in Germany, Netherlands and Belgium. Ingo Klare's co-authors include Wolfgang Witte, Guido Werner, Carola Konstabel, H. Claus, H. Heier, Rolf Reissbrodt, Carola Fleige, Geert Huys, G Böhme and Jennifer K. Bender and has published in prestigious journals such as PLoS ONE, Applied and Environmental Microbiology and Scientific Reports.

In The Last Decade

Ingo Klare

97 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingo Klare Germany 36 2.5k 1.4k 1.4k 1.2k 918 98 4.4k
Janetta Top Netherlands 36 3.4k 1.3× 2.0k 1.4× 1.4k 1.0× 643 0.5× 715 0.8× 78 4.9k
Guido Werner Germany 48 3.9k 1.5× 2.4k 1.7× 2.4k 1.7× 1.2k 1.0× 1.9k 2.1× 200 6.9k
Andrea T. Feßler Germany 35 2.6k 1.0× 947 0.7× 1.7k 1.3× 634 0.5× 1.0k 1.1× 124 4.0k
Damian C. Melles∗ Netherlands 26 3.2k 1.2× 1.2k 0.9× 2.0k 1.4× 354 0.3× 747 0.8× 60 4.8k
Max Heck Netherlands 32 1.6k 0.6× 860 0.6× 910 0.7× 921 0.7× 592 0.6× 50 2.9k
José M. Munita Chile 29 2.0k 0.8× 964 0.7× 1.4k 1.1× 531 0.4× 1.7k 1.8× 108 4.9k
Xander W. Huijsdens Netherlands 26 2.5k 1.0× 1.2k 0.8× 1.8k 1.3× 506 0.4× 382 0.4× 34 3.5k
Stefan Monecke Germany 43 4.8k 1.9× 2.1k 1.4× 3.5k 2.5× 757 0.6× 804 0.9× 221 6.6k
D.F. Sahm United States 28 1.6k 0.6× 979 0.7× 608 0.4× 454 0.4× 1.3k 1.4× 56 3.4k
Robin Köck Germany 36 2.3k 0.9× 862 0.6× 1.2k 0.9× 525 0.4× 784 0.9× 86 3.7k

Countries citing papers authored by Ingo Klare

Since Specialization
Citations

This map shows the geographic impact of Ingo Klare's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingo Klare with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingo Klare more than expected).

Fields of papers citing papers by Ingo Klare

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingo Klare. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingo Klare. The network helps show where Ingo Klare may publish in the future.

Co-authorship network of co-authors of Ingo Klare

This figure shows the co-authorship network connecting the top 25 collaborators of Ingo Klare. A scholar is included among the top collaborators of Ingo Klare based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingo Klare. Ingo Klare is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kresken, Michael, Ingo Klare, Thomas A. Wichelhaus, et al.. (2021). Glycopeptide resistance in Enterococcus spp. and coagulase-negative staphylococci from hospitalised patients in Germany: occurrence, characteristics and dalbavancin susceptibility. Journal of Global Antimicrobial Resistance. 28. 102–107. 12 indexed citations
2.
Bender, Jennifer K., Ingo Klare, Carola Fleige, & Guido Werner. (2020). A Nosocomial Cluster of Tigecycline- and Vancomycin-Resistant Enterococcus faecium Isolates and the Impact of rpsJ and tet (M) Mutations on Tigecycline Resistance. Microbial Drug Resistance. 26(6). 576–582. 11 indexed citations
3.
Klare, Ingo, Jennifer K. Bender, Carola Fleige, et al.. (2019). Comparison of VITEK® 2, three different gradient strip tests and broth microdilution for detecting vanB-positive Enterococcus faecium isolates with low vancomycin MICs. Journal of Antimicrobial Chemotherapy. 74(10). 2926–2929. 7 indexed citations
4.
Werner, Guido, Carola Fleige, Ingo Klare, Robert E. Weber, & Jennifer K. Bender. (2019). Validating a screening agar for linezolid-resistant enterococci. BMC Infectious Diseases. 19(1). 1078–1078. 8 indexed citations
5.
Messler, Sabine, Ingo Klare, Frank Wappler, et al.. (2018). Reduction of nosocomial bloodstream infections and nosocomial vancomycin-resistant Enterococcus faecium on an intensive care unit after introduction of antiseptic octenidine-based bathing. Journal of Hospital Infection. 101(3). 264–271. 14 indexed citations
6.
Weber, Robert E., Franziska Layer, Ingo Klare, Guido Werner, & Birgit Strommenger. (2017). Comparative evaluation of VITEK® 2 and three commercial gradient strip assays for daptomycin susceptibility testing of Staphylococcus aureus. Journal of Antimicrobial Chemotherapy. 72(11). 3059–3062. 2 indexed citations
7.
Bender, Jennifer K., Carola Fleige, Ingo Klare, et al.. (2016). Detection of a cfr(B) Variant in German Enterococcus faecium Clinical Isolates and the Impact on Linezolid Resistance in Enterococcus spp.. PLoS ONE. 11(11). e0167042–e0167042. 45 indexed citations
8.
Krüll, Matthias, Ingo Klare, Birgit Ross, et al.. (2016). Emergence of linezolid- and vancomycin-resistant Enterococcus faecium in a department for hematologic stem cell transplantation. Antimicrobial Resistance and Infection Control. 5(1). 31–31. 23 indexed citations
9.
Boyle, Breida, et al.. (2015). Epidemiology and molecular typing of VRE bloodstream isolates in an Irish tertiary care hospital. Journal of Antimicrobial Chemotherapy. 70(10). 2718–2724. 31 indexed citations
10.
Daeschlein, Georg, Matthias Napp, Sebastian von Podewils, et al.. (2013). In Vitro Susceptibility of Multidrug Resistant Skin and Wound Pathogens Against Low Temperature Atmospheric Pressure Plasma Jet (APPJ) and Dielectric Barrier Discharge Plasma (DBD). Plasma Processes and Polymers. 11(2). 175–183. 102 indexed citations
11.
Kola, Axel, Frank Schwab, Sina Bärwolff, et al.. (2009). Is there an association between nosocomial infection rates and bacterial cross transmissions?*. Critical Care Medicine. 38(1). 46–50. 20 indexed citations
12.
Grundmann, Hajo, Sina Bärwolff, Adriana Tami, et al.. (2005). How many infections are caused by patient-to-patient transmission in intensive care units?*. Critical Care Medicine. 33(5). 946–951. 98 indexed citations
13.
Schulte, Berit, Ingo Klare, Birgit Strommenger, et al.. (2005). Linezolid-resistant E. faecium isolated from an open joint fracture: A report of the first isolate from Italy?. International Journal of Hygiene and Environmental Health. 208(6). 477–480. 2 indexed citations
14.
Bärwolff, Sina, Hajo Grundmann, Frank Schwab, et al.. (2005). Inzidenz der Übertragung von Infektionserregern von einem Intensivpatienten zum anderen. Der Anaesthesist. 54(6). 560–566. 2 indexed citations
15.
Witte, Wolfgang & Ingo Klare. (1999). Antibiotikaresistenz bei bakteriellen Infektionserregern Mikrobiologisch-epidemiologische Aspekte. Publication server of the Robert Koch Institute (Robert Kock Institute). 42(1). 8–16. 3 indexed citations
16.
Witte, Wolfgang, Ingo Klare, & Guido Werner. (1999). Selective pressure by antibiotics as feed additives. Infection. 27(S2). S35–S38. 38 indexed citations
17.
Witte, Wolfgang, Christiane Cuny, C Braulke, D Heuck, & Ingo Klare. (1997). Large dissémination de MRSA épidémique dans les hôpitaux allemands. Eurosurveillance. 2(4). 25–28. 1 indexed citations
18.
Klare, Ingo. (1995). vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiology Letters. 125(2-3). 165–171. 29 indexed citations
19.
Klare, Ingo, H. Heier, H. Claus, Rolf Reissbrodt, & Wolfgang Witte. (1995). vanA-mediated high-level glycopeptide resistance inEnterococcus faeciumfrom animal husbandry. FEMS Microbiology Letters. 125(2-3). 165–172. 256 indexed citations
20.
Witte, Wolfgang & Ingo Klare. (1995). Glycopeptide-Resistant Enterococcus faecium Outside Hospitals: A Commentary. Microbial Drug Resistance. 1(3). 259–263. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Janetta Top Breakdown of academic impact, for papers by Guido Werner Breakdown of academic impact, for papers by Andrea T. Feßler Breakdown of academic impact, for papers by Damian C. Melles∗ Breakdown of academic impact, for papers by Max Heck Breakdown of academic impact, for papers by José M. Munita Breakdown of academic impact, for papers by Xander W. Huijsdens Breakdown of academic impact, for papers by Stefan Monecke Breakdown of academic impact, for papers by D.F. Sahm Breakdown of academic impact, for papers by Robin Köck
Rankless by CCL
2026